HYPOTENALOL

This brand name is authorized in Nigeria.

Active ingredients

The drug HYPOTENALOL contains one active pharmaceutical ingredient (API):

`1`	Labetalol UNII `1GEV3BAW9J` - LABETALOL HYDROCHLORIDE
	Labetalol lowers the blood pressure by blocking peripheral arteriolar alphaadrenoceptors thus reducing peripheral resistance, and by concurrent betablockade, protects the heart from reflex sympathetic drive that would otherwise occur.
	Read more about Labetalol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1495	Tablet	Hypotenalol 200 Tablets TAB 200 mg		21/12/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AG01	Labetalol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AG Alpha and beta blocking agents
Discover more medicines within C07AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1495

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.